---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-057732"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T01:30:19.563311+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q3 GAAP EPS $0.26, Adjusted EPS $0.32; FY guidance $200-210M

## Summary
- Q3 GAAP EPS $0.26 vs $0.35 YoY; Adjusted EPS $0.32 vs $0.40.
- Net revenue $506.6M (+3.4% YoY) but same-unit patient volume declined 1.2%.
- Adjusted EBITDA $50.4M, down 13.5% from $58.3M; practice costs rose to $368.4M.
- FY2023 Adjusted EBITDA guidance $200-210M; first nine months $149.6M implies soft Q4.
- Terminated R1 RCM contract effective Dec 15, 2023; plans hybrid revenue cycle model.

## SEC filing metadata
- accession: 0000950170-23-057732
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/md-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-057732
- JSON: https://secwatch.observer/filing/0000950170-23-057732.json
- Plain text: https://secwatch.observer/filing/0000950170-23-057732.txt

## Key facts
- Earnings Releases
  Pediatrix Medical Group, Inc. reported financial results for three months ended September 30, 2023.
  - Period: three months ended September 30, 2023
  - Result: reported results
  source text: On November 2, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2023 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm
- Earnings Releases
  Pediatrix Medical Group, Inc. reported financial results for nine months ended September 30, 2023.
  - Period: nine months ended September 30, 2023
  - Result: reported results
  source text: On November 2, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2023 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.